Uveitis Treatment Market to Exhibit a Healthy Growth of 7.3% CAGR Between 2014-2020

By , in PR PR Health on .

Albany, NY — 11/17/2017 — According to a new market report published by Persistence Market Research “Global Market Study on Uveitis Treatment: Asia to Witness fastest Growth by 2020,” the global uveitis treatment market was valued at USD 539.0 million in 2014 and is expected to expand at a CAGR of 7.3% from 2014 to 2020, to reach USD 822.5 million by 2020.

Globally, the uveitis treatment market is witnessing significant growth due to increasing prevalence of uveitis and related complications, and increasing aging population. Moreover, increasing R&D investments in drug discovery and development, and growing government initiatives to reduce eye disorders are also driving the growth of the market. However, lack of awareness about eye disorders, poor primary healthcare infrastructure, and lack of health insurance in developing countries are inhibiting the growth of the uveitis treatment market. The global uveitis treatment market is anticipated to grow from an estimated USD 539.0 million in 2014 to USD 822.5 million by 2020 at a CAGR of 7.3% during the forecast period.

Request Report TOC @ https://www.persistencemarketresearch.com/toc/4430

In North America, rising incidence of uveitis and related disorders, increasing aging population, and growing R&D investments by drug manufacturing companies for the development of innovative products to treat the disease in the region are driving the uveitis treatment options such as corticosteroids in the market. For instance, in North America, approximately 500,000 people are affected by uveitis every year; out of these, approximately 50,000 new blind cases occur due to uveitis, which accounts for approximately 10% of the overall blind cases in the region.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/4430

In Europe, the uveitis treatment market is driven by rising number of autoimmune disorders such as AIDS and multiple sclerosis. Moreover, in Germany, the market is evolving due to rising aging population and increasing the prevalence of eye disorders. However, in Asia, the growth for uveitis treatment is higher than that in developed regions, due to increasing prevalence of uveitis and growing aging population.

pSivida Corp., XOMA Corporation, Alcon, Inc., Allergan, Inc., AbbVie Inc., Enzo Biochem Inc., OphthaliX Inc., Bausch & Lomb Incorporated, Regeneron Pharmaceuticals, Inc, and Santen Pharmaceutical Co., Ltd. are some of the major players in the uveitis treatment market.

Buy Uveitis Treatment Market Report @ https://www.persistencemarketresearch.com/checkout/4430

The following two tabs change content below.
Brad Bennett

Brad Bennett

Brad grew up in a small town in northern Iowa. He studied chemistry in college, graduated, and married his wife one month later. They were then blessed with two baby boys within the first four years of marriage. Having babies gave their family a desire to return to the old paths – to nourish their family with traditional, homegrown foods; rid their home of toxic chemicals and petroleum products; and give their boys a chance to know a simple, sustainable way of life. They are currently building a homestead from scratch on two little acres in central Texas. There’s a lot to be done to become somewhat self-sufficient, but they are debt-free and get to spend their days living this simple, good life together with their five young children.
%d bloggers like this: